Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy.

Spencer, S K M; Pommier, A J C; Morgan, S R; Barry, S T; Robertson, J D; Hoff, P M; Jürgensmeier, J M

Spencer, S K M; Pommier, A J C; Morgan, S R; Barry, S T; Robertson, J D; Hoff, P M; Jürgensmeier, J M.

Affiliation

Spencer SK; Clinical Oncology, AstaZeneca, Macclesfield, UK.

Br J Cancer ; 109(11): 2765-73, 2013 Nov 26.

Article in En | MEDLINE | ID: mdl-24149180

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Blood Proteins/analysis; Colorectal Neoplasms/diagnosis; Colorectal Neoplasms/drug therapy; Deoxycytidine/analogs & derivatives; Fluorouracil/analogs & derivatives; Quinazolines/administration & dosage; Biomarkers/blood; Capecitabine; Colorectal Neoplasms/blood; Colorectal Neoplasms/mortality; Deoxycytidine/therapeutic use; Double-Blind Method; Female; Fluorouracil/therapeutic use; Follow-Up Studies; Humans; Leucovorin/therapeutic use; Male; Organoplatinum Compounds/therapeutic use; Oxaloacetates; Placebos; Predictive Value of Tests; Prognosis; Survival Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Blood Proteins / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Br J Cancer Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google